Confirmed Preliminary Control Unknown Transaction verified Personal CareConsumer Health

ANUSOL and RECTINOL acquired by Church & Dwight Co., Inc.

Church & Dwight Co., Inc. agreed to acquire ANUSOL and RECTINOL, a personal care brand, on Dec 15, 2016.

Preliminary: The transaction value and EV/revenue are not yet independently verified.

Transaction summary

Target
ANUSOL and RECTINOL
Announced
2016-12-15
Geography
-
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-10-18
Latest update
2026-10-31

Value and multiples

100% enterprise value

USD 130M

Unverified

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

5.42x

Unverified

Period: FY2016

Basis: Public source

EV / EBITDA

-

EBITDA basis not stated

Basis: Public source

Amounts paid and other reported values

Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.

Consideration: USD 130M

US$130m.

Basis

  • Reported consideration: USD 130m.
  • Implied EV / revenue is 5.42x, calculated from USD 130m value and USD 24.0m revenue.
  • Metric period: FY2016 2016.

Source summary

Church & Dwight 10-K, filed 2026-02-12

Confirmed

Acquisition of ANUSOL and RECTINOL by Church & Dwight Co., Inc.

Open source

Church & Dwight 10-K, filed 2026-02-12

Confirmed

the ANUSOL and RECTINOL businesses from Johnson & Johnson (the “Anusol Acquisition”)

Open source

Church & Dwight 10-K, filed 2026-02-12

Confirmed

CHURCH & DWIGHT CO., INC. (Exact name of registrant as specified in its charter)

Open source

Continue your research

Explore more comps →